This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Shionogi, Inc.. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2014
Title: The Innovative Contributions of Susan P. Clausen
Introduction
Susan P. Clausen is a notable inventor based in Ijamsville, MD (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of modified release antibiotic products. With a total of 3 patents to her name, her work has had a meaningful impact on antibiotic efficacy and patient treatment.
Latest Patents
One of her latest patents is focused on modified release amoxicillin products. This invention comprises at least one modified release component that includes amoxicillin and a pharmaceutically acceptable carrier. The product is designed to exhibit a specific pharmacokinetic profile when administered to patients in the fed state. Another significant patent involves compositions and methods for improving the efficacy of penicillin-type antibiotics. This invention includes once-a-day penicillin-type antibiotic products that provide effective serum levels for at least five consecutive hours within a 24-hour dosing interval.
Career Highlights
Susan P. Clausen is currently associated with Shionogi, Inc., where she continues to innovate in the pharmaceutical sector. Her work is characterized by a commitment to enhancing the effectiveness of antibiotic treatments, which is crucial in the fight against bacterial infections.
Collaborations
Throughout her career, Susan has collaborated with esteemed colleagues such as Henry H. Flanner and Donald Treacy. These partnerships have contributed to the advancement of her research and the successful development of her patented products.
Conclusion
Susan P. Clausen's contributions to the field of pharmaceuticals through her innovative patents demonstrate her dedication to improving antibiotic treatments. Her work continues to influence the medical community and enhance patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
